Analysis of 2013 European LeukaemiaNet (ELN) responses in chronic phase CML across four frontline TKI modalities and impact on clinical outcomes

This study assessed the relevance of 2013 European LeukaemiaNet (ELN) response categories on patients treated with common frontline tyrosine kinase inhibitors (TKI) in chronic myeloid leukaemia in chronic phase (CML-CP) . Four hundred and eighty-seven patients treated with imatinib (400 mg; IM 400,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Haematol
Main Authors: Jain, Preetesh, Kantarjian, Hagop, Sasaki, Koji, Jabbour, Elias, Dasarathula, Jyothsna, Gonzalez, Graciela Nogueras, Verstovsek, Srdan, Borthakur, Gautam, Wierda, William, Kadia, Tapan, Dellasala, Sara, Pierce, Sherry, Ravandi, Farhad, O’Brien, Susan, Cortes, Jorge
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4809772/
https://ncbi.nlm.nih.gov/pubmed/26846160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13936
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados